Matthew Callahan

Matthew Callahan was the founder of Botanix Pharmaceuticals Ltd., founded in 2016, serving as Executive Director from 2016 to 2019 and again from 2020 to 2025.
Mr. Callahan is the founder of iCeutica, Inc., founded in 2005, holding the title of President & Chief Executive Officer.
Mr. Callahan is the founder of Stone Ridge Ventures Pty Ltd., founded in 2005, serving as Investment Director.
Mr. Callahan is the founder of Rumin8 Ltd., founded in 2021, holding the title Head-Regulatory.
Current jobs include Chief Executive Officer at Churchill Pharmaceuticals; Non-Executive Director at Intellection Pty Ltd.; Director at Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016; Executive Director at Botanix Pharmaceuticals, Inc.; Non-Executive Director at Nemgenix Pty Ltd.; Non Executive Director at Matteo Mining Corp.
Pty Ltd.; Director at Glycan Bioscience LLC; Director at Thylacine Consulting LLC; Executive Director at Respirion Pharmaceuticals Pty Ltd.; and Director at Microsize, Inc.Former jobs include Chief Executive Officer at Dimerix Bioscience Pty Ltd. from 2003 to 2005; Director at The Cash Store Australia Holdings, Inc. in 2009; Director at Glycan Biosciences, Inc. from 2006 to 2011; Non-Executive Director at Orthocell Ltd. from 2006 to 2019 and from 2020 to 2023; Non-Executive Director at Emyria Ltd. from 2018 to 2023; Director - Sales Excellence at Riverside Partners LLC (New York); General Manager at Xelor Software, Inc.; and General Manager & General Counsel at Nearmap Pty Ltd.Education includes undergraduate and MBAistration degrees from The University of Western Australia.